U.S., May 8 -- ClinicalTrials.gov registry received information related to the study (NCT06960863) titled 'Fibroscan Evaluating Immunotherapy Response in Hepatocellular Carcinoma' on April 29.
Brief Summary: The goal of this prospective cohort study is to evaluate the role of transient elastography (Fibroscan) in predicting the response of immunotherapy in advanced Hepatocellular carcinoma (HCC) patients.
Researchers will predict the response to 6 months of HCC immunotherapy regarding improvement of the degree of liver fibrosis, development of liver decompensation, complications, survival, and mortality.
Participants will undergo history-taking, clinical examination, laboratory investigations, Child-Pugh classification, Model for End-sta...